drugset / Trial / NCT01356004

Effective Study of Live Attenuated Varicella Vaccine to Treat Severe Resistant Psoriasis

NCT01356004 ↗

Phase 4 Completed 35 enrolled Cairo University
RandomizedParallel-groupDouble-blindTreatment

Summary

Immunotherapy was reported in the treatment of psoriasis. Treatment of resistant psoriasis may be difficult and cyclosporine can induce some remission. The investigators hypothesized that the combined use of live attenuated varicella vaccine as an adjuvant therapy to low dose cyclosporine in the treatment of severe resistant psoriasis can give positive responses.

Timeline

Start
2010-01
Primary completion
2010-05
Completion
2010-11

Drugs

EvaluationDrugModalityDoseRoute
Subject live attenuated chicken pox vaccine Vaccine 0.5 ml Subcutaneous

Indications